Also from this source

You just read:

CSL Behring Announces New Vial Size of Privigen® for Treatment of Primary Immunodeficiency and Chronic Immune Thrombocytopenic Purpura

News provided by

CSL Behring

Feb 21, 2013, 09:00 EST